moved for leave to introduce Bill C-349, An Act to amend the Patent Act.
Mr. Speaker, this is the second time I have introduced this legislation into the House of Commons.
It deals with patent protection and also the issue of evergreening where legal loopholes extend the patent protection of certain drugs that then cost Canadians significant sums of money, not only to individuals but also in employment benefit plans as well as the organizations that actually provide that across the country.
This will lower drug costs, provide fairness, and make us more similar to the United States. The Americans actually have a more progressive generic drug industry because they have enacted legislation to stop the legal litigation. Most important, it will promote innovation.
(Motions deemed adopted, bill read the first time and printed)